ADAA Member Research News: Latest Anxiety, Depression, and Mental Health Papers

ADAA Member Research News

Below is a curated listing of recent research and clinically focused publications by ADAA members. To ensure accuracy and relevance in a rapidly evolving field, only work published within the past two to three years is featured, even though members may have additional earlier publications.

ADAA also offers CE/CME credits through its Annual Conference, which brings together leading experts in anxiety, depression, and co-occurring disorders for in-depth learning and professional development. The conference typically offers up to 26 credits as part of registration.

• Submit to ADAA's Journal of Mood and Anxiety Disorders®
• To stay informed about upcoming CE/CME opportunities, including webinars and conference programming, sign up for the ADAA newsletter
• If you are an ADAA member and would like to share eligible research news on ADAA’s website, please contact Lise Bram.

ADAA Member Research Studies (available through online sites). Most recent publications are listed first. 

• 07/02/2026 Barriers to Understanding How Many People Use AI For Mental Health Support: Anestimate and Narrative Review, Nature, John Torous, MD
• 06/29/2026 Specialized or General-Purpose—The Wrong Question for Mental Health AI Safety, Jama Network, John Torous, MD
• 06/28/2026 The Effects of Vinyasa Yoga, Resistance Training, and Passive Stretching on Mental Health and Anxiety-Related Vulnerability Factors: A Randomized Controlled Trial, Elsevier, Gordon J. Asmundson, PhD
• 05/31/2026 Activating this nerve can relieve stress. Here’s how to do it, Washington Post, Christopher W. Austelle, MD
• 05/27/2026 Anxiety Sensitivity and Intolerance of Uncertainty Track Distinct Neurobehavioral Dimensions of Avoidance in Anxiety-Related Disorders, Nature, Hannah Berg
• 05/19/2026 Surprising Drug Combo Could Reshape Treatment for Suicide Risk, Washington Post, Ned Kalin, MD
• 05/19/2026 Personalized Machine Learning Guided Intervention for Optimizing Lifestyle Behaviors in Depression: A Pilot Study, Nature, Jyoti Mishra, PhD, MBA
• 05/18/2026 Associations Between Residential Segregation, Ambient Air Pollution, and Hippocampal Features in Recent Trauma Survivors, Nature, Sanne J. H. van Rooij, PhD, Tanja Jovanovic, PhD (ADAA President Elect), Scott Rauch, MD, Ronald Kessler, PhD, Kerry Ressler, MD, PhD, Jennifer Stevens, PhD, and Nathaniel Harnett, PhD
• 05/15/2026 Is Ketamine for Depression Moving Too Fast on Weak Data?, Medscape, Charles Nemeroff, MD, PhD (ADAA Past President)
• 05/14/2026 Post-Traumatic Stress Disorder, National Library of Medicine (National Center for Biotechnology Information, Kerry Ressler (ADAA Past President), MD, PhD, Barbara Rothbaum, PhD, ABPP, Ronald Kessler, PhD
• 05/01/2026 In the Race to the First Psychedelic Approval, Who’s Leading?, Medscape, Charles B. Nemeroff, MD, PhD (ADAA Past President)
• 04.28/2026 Positive Affect Therapy with Dr Alicia Meuret, Practice Matters Podcast Series, Alicia E. Meuret, PhD (ADAA Board member)
• 04/27/2026 New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose, US News and World Report, Alicia E. Meuret, PhD
• 04/23/2026 Augmenting Extinction With Counterconditioning Strengthens and Sustains Neural Safety Representations in PTSD, Nature, Charles Nemeroff, MD, PhD (ADAA Past President)
• 04/22/2026 EMP-01 for Social Anxiety Disorder Demonstrates Meaningful Improvements in Phase 2a Study, Psychiatric Times, Murray Stein, MD, MPH, FRCPC
• 04/20/2026 Brain Stimulation Improves PTSD Symptoms, Futurity, Sanne van Rooij, PhD
• 04/06/2026 Oxytocin Dynamics and Synchrony in Mother-Child Dyads: Long-Term Neuroendocrine Effects of Maternal Institutionalization, Science Direct, Marina Zhukova, PhD
• 04/01/2026 Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial, Psychiatry Online, Sanne J. van Rooij, PhD, Cecilia A. Hinojosa, PhD, Rebecca Lipschutz, PhD, Kerry Ressler, MD, PhD, and Tanja Jovanovic, PhD
• 03/12/2026 State of the Science: MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder, Wiley Online Library,  Barbara O. Rothbaum, PhD, ABPP, Lauren M. Sippel, PhD, Jessica Maples-Keller, PhD
• 03/06/2026 Investigational Drugs in PTSD, Nature, Kerry Ressler, MD, PhD, (ADAA Past Board Member)
• 02/11/2026 Major Depressive Disorder Shares Immune Abnormalities and Potential Therapies with Inflammatory Skin Diseases, Medical Press, James Murrough, MD, PhD
• 02/10/2026 TMS in Adolescent Depression: A Milestone FDA Clearance, Molecular Psychiatry, Charles Nemeroff, MD, PhD (ADAA Past President)
• 10/30/2025 Study Finds Anhedonia Symptoms Are Especially Vulnerable in Major Depression Patients with High Bodily Inflammation Levels, Brain and Behavior Foundation, Sahib Khalsa, MD, PhD, and Martin P. Paulus, MD (ADAA Board Member)
• 09/24/2025 Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds, eClinicalMedicine, Gregory Fonzo, PhD
• 06/05/2024 Researchers Find Shared Multiomic Molecular Dysregulations in Brains With PTSD and MDD, Pharmacy Times, Kerry Ressler, MD, PhD, and Charles Nemeroff, MD, PhD
• 02/07/2024 Brief Report: Supporting Families in Intensive Treatment for Pediatric Anxiety and Obsessive-Compulsive Disorders, Pace University, Jacqueline Sperling, PhD
• 03/14/2024 Anxiety therapy prior to COVID-19 pandemic shields against increased stress, News Medical Life Sciences, David Rosmarin, PhD
• 01/06/2024 Processes of change in a randomized clinical trial of radically open dialectical behavior therapy (RO DBT) for adults with treatment-refractory depression., American Psychological Association, R. Trent Codd III, EdS
• 11/9/2022 Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders, A Randomized Clinical Trial, JAMA Psychiatry, Elizabeth Hoge, MD

View ADAA member publications for clinicians, researchers,and the public.